{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:53:50Z","timestamp":1788339230586,"version":"build-2803163510"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1176\/appi.psy.48.6.530","type":"journal-article","created":{"date-parts":[[2007,12,10]],"date-time":"2007-12-10T21:13:14Z","timestamp":1197321194000},"page":"530-531","source":"Crossref","is-referenced-by-count":44,"title":["Quetiapine-Induced Leucopenia and Thrombocytopenia"],"prefix":"10.1016","volume":"48","author":[{"given":"B.","family":"Ravi Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.48.6.530_bib0005","series-title":"Meyler's Side Effects of Drugs","first-page":"117","article-title":"Neuroleptics and antipsychotics","author":"Simpson","year":"1996"},{"key":"10.1176\/appi.psy.48.6.530_bib0010","first-page":"35","article-title":"Clozapine-associated agranulocytosis: a review of international experience","volume":"22","author":"Lamarque","year":"1996","journal-title":"Encephale"},{"key":"10.1176\/appi.psy.48.6.530_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01064682","article-title":"Clinical profile of clozapine: adverse reactions and agranulocytosis","volume":"62","author":"Lieberman","year":"1992","journal-title":"Psychiatr Q"},{"key":"10.1176\/appi.psy.48.6.530_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1176\/appi.psy.48.6.530_bib0025","unstructured":"Zeneca Pharma Ltd. Seroquel\u00ae (quetiapine). Product monograph, 1998, pp 1\u201325."},{"key":"10.1176\/appi.psy.48.6.530_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/13543784.4.4.291","article-title":"Preclinical pharmacology of new atypical antipsychotics in late-stage development","volume":"4","author":"Goldstein","year":"1995","journal-title":"Exp Opin Invest Drugs"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003331820770991X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003331820770991X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T04:54:48Z","timestamp":1546404888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003331820770991X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S003331820770991X"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.48.6.530","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}